- Home
- IBRX vs AMBP Comparison
IBRX vs AMBP Comparison
Compare IBRX & AMBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- AMBP
- Stock Information
- Founded
- IBRX 2014
- AMBP 2021
- Country
- IBRX United States
- AMBP Luxembourg
- Employees
- IBRX N/A
- AMBP N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- AMBP Containers/Packaging
- Sector
- IBRX Health Care
- AMBP Industrials
- Exchange
- IBRX Nasdaq
- AMBP Nasdaq
- Market Cap
- IBRX 2.3B
- AMBP 2.2B
- IPO Year
- IBRX N/A
- AMBP N/A
- Fundamental
- Price
- IBRX $2.31
- AMBP $3.65
- Analyst Decision
- IBRX Strong Buy
- AMBP Buy
- Analyst Count
- IBRX 5
- AMBP 4
- Target Price
- IBRX $10.20
- AMBP $4.40
- AVG Volume (30 Days)
- IBRX 9.0M
- AMBP 1.1M
- Earning Date
- IBRX 08-05-2025
- AMBP 10-23-2025
- Dividend Yield
- IBRX N/A
- AMBP 10.97%
- EPS Growth
- IBRX N/A
- AMBP N/A
- EPS
- IBRX N/A
- AMBP N/A
- Revenue
- IBRX $56,600,000.00
- AMBP $5,231,000,000.00
- Revenue This Year
- IBRX $629.94
- AMBP $11.74
- Revenue Next Year
- IBRX $109.91
- AMBP $2.02
- P/E Ratio
- IBRX N/A
- AMBP N/A
- Revenue Growth
- IBRX 4227.22
- AMBP 8.39
- 52 Week Low
- IBRX $1.83
- AMBP $2.50
- 52 Week High
- IBRX $7.48
- AMBP $4.78
- Technical
- Relative Strength Index (RSI)
- IBRX 45.80
- AMBP 34.76
- Support Level
- IBRX $2.17
- AMBP $3.64
- Resistance Level
- IBRX $2.43
- AMBP $3.72
- Average True Range (ATR)
- IBRX 0.15
- AMBP 0.10
- MACD
- IBRX 0.00
- AMBP 0.00
- Stochastic Oscillator
- IBRX 27.92
- AMBP 7.89
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. The company deals with multiple categories of products including beer, carbonated soft drinks, energy drinks, hard seltzers, juices, pre-mixed cocktails, teas, sparkling waters, and wine. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.